Responding to a story published today in The Times, the Association of the British Pharmaceutical Industry (ABPI) have issued the following statement.Read more
The global threat of antimicrobial resistance (AMR) has the potential to affect everyone and it can’t be taken lightly. Our over-use of these life-saving drugs, across the world, has led to a dramatic rise in drug-resistant infections. This poses such a threat to global health that for only the fourth time in its history the United Nations has called on World leaders to reach a declaration on a health issue. HIV, non-communicable diseases, and most recently, Ebola being the others.Read more
The Association of the British Pharmaceutical Industry (ABPI) have welcomed the publication of a new ‘Roadmap for Progress on Combating Antimicrobial Resistance (AMR)’, by more than 13 global pharmaceutical companies (10 ABPI member companies).Read more
The Association of the British Pharmaceutical Industry (ABPI) has published details of payment to the Department of Health (DH) under the five-year Pharmaceutical Price Regulation Scheme (PPRS).Read more
Our website is not compatible with Internet Explorer 8. If you are experiencing problems with scrolling please upgrade to a later version or use another browser.
Board of management
Developing new medicines –
Industry acronym buster